INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Regenerative medicine laws and requirements in Montana. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Unapproved Cell Therapies | do not explicitly permit sources differ | Mont. Code Ann. § 50-12-102(1)“"Experimental treatment" means the provision of a medical intervention by a health care provider involving an investigational drug, biological product, device, or other treatment that has successfully completed phase 1 of a clinical trial but has not yet been approved”Note: Montana's Right to Try Act (as amended in 2025, Ch. 621, L. 2025, reported as SB 535, creating experimental treatment centers) covers investigational drugs, biological products and devices generally; it does not expressly mention stem cells or cell therapies. Cell therapies may fall within 'biological product', so the stem-cell-specific category fits poorly. | Link | 2026-10-09 | medium |
| Require Patient Disclosure for Cell Therapies | do not require disclosure sources differ | Mont. Code Ann. § 50-12-105“(1) A patient or a patient's legal guardian shall provide informed consent to receive an experimental treatment.”Note: General Right to Try informed consent applies to any experimental treatment; no stem-cell-specific notice. Montana's Right to Try Act (as amended in 2025, Ch. 621, L. 2025, reported as SB 535, creating experimental treatment centers) covers investigational drugs, biological products and devices generally; it does not expressly mention stem cells or cell therapies. Cell therapies may fall within 'biological product', so the stem-cell-specific category fits poorly. | Link | 2026-10-09 | medium |
| Limit Practitioner Scope for Cell Therapies | No stem-cell-specific provision. Under the general Right to Try Act, experimental treatments may be provided by physicians, prescribing APRNs, physician assistants, and registered nurses at experimental treatment centers. sources differ | Mont. Code Ann. § 50-12-102(4)“(a) a physician; (b) an advanced practice registered nurse authorized by the board of nursing to prescribe medicine; (c) a physician assistant; and (d) a registered nurse performing services at an experimental treatment center.”Note: Montana's Right to Try Act (as amended in 2025, Ch. 621, L. 2025, reported as SB 535, creating experimental treatment centers) covers investigational drugs, biological products and devices generally; it does not expressly mention stem cells or cell therapies. Cell therapies may fall within 'biological product', so the stem-cell-specific category fits poorly. | Link | 2026-10-09 | medium |
| Have Cell Therapy Statute References | No stem-cell-specific statute; general Right to Try Act, Mont. Code Ann. §§ 50-12-101 to 50-12-110 (amended by Ch. 621, L. 2025). | Mont. Code Ann. § 50-12-102 (history note)“History: En. Sec. 2, Ch. 135, L. 2015; amd. Sec. 14, Ch. 88, L. 2023; amd. Sec. 1, Ch. 413, L. 2023; amd. Sec. 6, Ch. 621, L. 2025.”Note: Stored 'Mont. Code Ann. 50-xx-xxx' was a placeholder. Montana's Right to Try Act (as amended in 2025, Ch. 621, L. 2025, reported as SB 535, creating experimental treatment centers) covers investigational drugs, biological products and devices generally; it does not expressly mention stem cells or cell therapies. Cell therapies may fall within 'biological product', so the stem-cell-specific category fits poorly. | Link | 2026-10-09 | high |
View full Montana profile (all layers) · Report an error on this page